Archives: Agenda

• Equipping patients with a better understanding of your trial to increase recruitment
• Modifying communication strategies to ensure patients feels fully informed with decision making and giving consent
• Incorporating health literacy in all stages of patient communication to ensure fully transparent clinical trials

• Designing a protocol that adapts to increased complexities in trials to shorten timelines
• Creating adaptable designs that allows flexibility during trials for increased efficiency
• Strengthening foundations of your trial with a clearly defined protocol ensuring the collection of valid data

• Navigate new regulatory requirements and complex study designs with larger sample sizes and a broader global footprint
• Implement country and site selection strategies that optimize FPI/LPI milestones
• Manage the complexities of enrollment, cohort management, safety review, and trial logistics across multiple regions
• Maintain a patient-centric approach to optimize study coordination and to benefit patienta

• Patient identification: how to find patients who are eligible to participate in trials for rare forms of cancer
• Collaborating with patient advocacy groups to facilitate and boost recruitment
• What makes recruiting for a rare cancer trial unique?

• Exploring communication methods that encourage a collaborative culture across a company
• Implementing a strategy that breaks down silos and redefines how teams work together
• How working closely with other teams can foster collaboration when working towards shared goals

There is an urgency to speed up clinical trial processes. To identify and eliminate operational inefficiencies that cause bottlenecks. To ensure concerted efforts from investigators and study teams, sponsors, and other key operational partners combine to conserve resources and time, and, most importantly, accelerate progress in cancer research.

This presentation explores just how to do so with key insights that look at how to attain:

• Data-driven Selection to Choose a Region for Your Trial Expansion
• Risk Response Strategies and a Mitigation Framework
• Clear Communication and a Culture of Accountability Among Partners
• Case Studies on Canada as a Trial Expansion Region